Technology area: Biotechnology & Pharmaceuticals
29 pending office actions • 12 clients • 28 examiners • 18 art units • 0 of 29 (0%) have an AI response strategy ready • 61 patents granted in the last 365 days
DUANE MORRIS LLP - NY works in Biotechnology & Pharmaceuticals and reports 28 pending office actions. The broader profile records 13370 career applications, placing the New York office’s current workload within a substantial firm-level prosecution record.
The resolved allowance rate is 87.71%. An average of 3.37 office actions per allowance indicates that allowed matters generally involve repeated examination activity rather than immediate resolution. For patent practitioners, the profile supports planning around continued claim development and responses while retaining a strong allowance outcome measure.
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 5 (17%) |
| §103 only | 4 (14%) |
| §102 only | 2 (7%) |
| §112 only | 6 (21%) |
| Double-patenting only | 1 (3%) |
| Double-patenting + other | 2 (7%) |
| Multi-statute (no §101) | 8 (28%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IBRAHIM, MEDINA AHMED | 2 | 87.4% | +12.2% |
| KUMAR, VINOD | 1 | 82.8% | +20.3% |
| ZHENG, LI | 1 | 83.5% | +13.0% |
| STEPHENS, REBECCA JOHANNA | 1 | 68.2% | +27.7% |
| SHEN, YANXIN NMN | 1 | 84.6% | +26.4% |
| SULLIVAN, BRIAN JAMES | 1 | 76.5% | +14.9% |
| STOCKDALE, JESSICA NICOLE | 1 | 51.4% | +33.3% |
| LOGSDON, CHARLES | 1 | 71.9% | +11.0% |
| TRAN, CHRISTINA L | 1 | 51.6% | +49.8% |
| CROW, ROBERT THOMAS | 1 | 41.6% | +32.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18631696 | BRASSICA PLANT RESISTANT TO DOWNY MILDEW | IBRAHIM, MEDINA AHMED | 30d overdue |
| 19327595 | CULTIVATED ROCKET VARIETY 88-CR31134 RZ | IBRAHIM, MEDINA AHMED | — |
| 19326034 | CULTIVATED ROCKET VARIETY 88-CR31138 RZ | KUMAR, VINOD | — |
| 19052708 | BROCCOLI VARIETY 25-BO239 RZ | ZHENG, LI | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18673456 | ALBUGO CANDIDA RESISTANCE GENE | DELEO, VICTORIA LYNN | 103d overdue |
| 18240461 | TRAINING OF INSTANT SEGMENTATION ALGORITHMS WITH PARTIALLY ANNOTATED IMAGES | LU, ZHIYU | 44d overdue |
| 18923953 | PERONOSPORA RESISTANCE IN SPINACIA OLERACEA | SHEN, YANXIN NMN | — |
| 18797867 | MODIFIED GENE FOR MORE EFFICIENT CULTIVATION OF CUCUMBER | STOCKDALE, JESSICA NICOLE | — |
| 18774411 | MODIFIED TOM2A GENE INVOLVED IN TOBAMOVIRUS RESISTANCE | LOGSDON, CHARLES | — |
| 18713281 | USE OF A THERMOPLASTIC, BIOBASED AND BIODEGRADABLE MATERIAL HAVING BRITTLE FRACTURE MECHANICS AS A SHELL FOR AN EGG OR EGG-REPLACEMENT PRODUCT, AND VEGAN EGG-REPLACEMENT PRODUCT ENCASED BY SUCH A SHELL | SALAMON, PETER A | — |
| 18713340 | VEGAN-BASED EGG YOLK SUBSTITUTE PRODUCT | DIOU BERDECIA, LUIS EUGENIO | — |
| 18501327 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | SIMMONS, CHRIS E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17371357 | CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER, ATHEROSCLEROSIS, DIABETES AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES | TRAN, CHRISTINA L | 79d overdue |
| 18631696 | BRASSICA PLANT RESISTANT TO DOWNY MILDEW | IBRAHIM, MEDINA AHMED | 30d overdue |
| 18798341 | HYBRID TOMATO VARIETY 72-MP0030 RZ | SULLIVAN, BRIAN JAMES | 8d overdue |
| 19327595 | CULTIVATED ROCKET VARIETY 88-CR31134 RZ | IBRAHIM, MEDINA AHMED | — |
| 19326034 | CULTIVATED ROCKET VARIETY 88-CR31138 RZ | KUMAR, VINOD | — |
| 19052708 | BROCCOLI VARIETY 25-BO239 RZ | ZHENG, LI | — |
| 19033739 | CYSDV RESISTANCE IN MEMBERS OF THE CUCURBITACEAE FAMILY | STEPHENS, REBECCA JOHANNA | — |
| 18923953 | PERONOSPORA RESISTANCE IN SPINACIA OLERACEA | SHEN, YANXIN NMN | — |
| Art Unit | Apps |
|---|---|
| 1662 | 6 |
| 1663 | 6 |
| 1637 | 1 |
| 1683 | 1 |
| 1793 | 1 |
| 1792 | 1 |
| 3643 | 1 |
| 1624 | 1 |
| 3796 | 1 |
| 1641 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19327595 | CULTIVATED ROCKET VARIETY 88-CR31134 RZ | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | IBRAHIM, MEDINA AHMED | 1662 | §112 | Non-Final OA | — | Pending | Sep 12, 2025 |
| 19326034 | CULTIVATED ROCKET VARIETY 88-CR31138 RZ | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | KUMAR, VINOD | 1663 | §112 | Non-Final OA | — | Pending | Sep 11, 2025 |
| 19052708 | BROCCOLI VARIETY 25-BO239 RZ | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | ZHENG, LI | 1662 | §112 | Non-Final OA | — | Pending | Feb 13, 2025 |
| 19033739 | CYSDV RESISTANCE IN MEMBERS OF THE CUCURBITACEAE FAMILY | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | STEPHENS, REBECCA JOHANNA | 1663 | DP | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18923953 | PERONOSPORA RESISTANCE IN SPINACIA OLERACEA | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | SHEN, YANXIN NMN | 1663 | §101§112 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18798341 | HYBRID TOMATO VARIETY 72-MP0030 RZ | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | SULLIVAN, BRIAN JAMES | 1663 | §112 | Non-Final OA | 8d overdue | Pending | Aug 08, 2024 |
| 18797867 | MODIFIED GENE FOR MORE EFFICIENT CULTIVATION OF CUCUMBER | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | STOCKDALE, JESSICA NICOLE | 1663 | §102§112 | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18774411 | MODIFIED TOM2A GENE INVOLVED IN TOBAMOVIRUS RESISTANCE | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | LOGSDON, CHARLES | 1662 | §102§103§112 | Non-Final OA | — | Pending | Jul 16, 2024 |
| 17371357 | CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER, ATHEROSCLEROSIS, DIABETES AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS | TRAN, CHRISTINA L | 1637 | §112 | Final Rejection | 79d overdue | Pending | Jul 09, 2024 |
| 18678050 | HIGH SENSITIVITY AND RAPID NUCLEIC ACID DETECTION | Git Applied Biotechnologies, Llc. | CROW, ROBERT THOMAS | 1683 | §103 | Non-Final OA | — | Pending | May 30, 2024 |
| 18713281 | USE OF A THERMOPLASTIC, BIOBASED AND BIODEGRADABLE MATERIAL HAVING BRITTLE FRACTURE MECHANICS AS A SHELL FOR AN EGG OR EGG-REPLACEMENT PRODUCT, AND VEGAN EGG-REPLACEMENT PRODUCT ENCASED BY SUCH A SHELL | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | SALAMON, PETER A | 1793 | §102§112 | Non-Final OA | — | Pending | May 24, 2024 |
| 18713340 | VEGAN-BASED EGG YOLK SUBSTITUTE PRODUCT | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | DIOU BERDECIA, LUIS EUGENIO | 1792 | §103§112 | Non-Final OA | — | Pending | May 24, 2024 |
| 18673456 | ALBUGO CANDIDA RESISTANCE GENE | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | DELEO, VICTORIA LYNN | 1662 | §101§102§103§112 | Non-Final OA | 103d overdue | Pending | May 24, 2024 |
| 18631696 | BRASSICA PLANT RESISTANT TO DOWNY MILDEW | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | IBRAHIM, MEDINA AHMED | 1662 | §103§112DP | Final Rejection | 30d overdue | Pending | Apr 10, 2024 |
| 18621666 | VEGETABLES, MUSHROOMS OR HERBS IN A BOX | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | NGUYEN, SON T | 3643 | §103 | Final Rejection | 46d overdue | Pending | Mar 29, 2024 |
| 18683412 | PRODRUGS FOR USE IN THE TREATMENT OF TISSUE DAMAGE | UCL Business Ltd | HABTE, KAHSAY | 1624 | §112Other | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18422869 | SYSTEMS AND METHODS FOR OPTIMIZING USE OF A MEDICAL DEVICE FOR PAIN MANAGEMENT | Biowave Corporation | STICE, PAULA J | 3796 | §103 | Final Rejection | 63d | Pending | Jan 25, 2024 |
| 18501327 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | Elian LLC | SIMMONS, CHRIS E | §102§103§112Other | Non-Final OA | — | Pending | Nov 03, 2023 | |
| 18459879 | CANCER THERAPY INVOLVING CAR-ENGINEERED T-CELLS AND PARVOVIRUS H-1 | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS | WEN, SHARON X | 1641 | §102§103 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18240461 | TRAINING OF INSTANT SEGMENTATION ALGORITHMS WITH PARTIALLY ANNOTATED IMAGES | Carl Zeiss Microscopy GmbH | LU, ZHIYU | 2665 | §101§103 | Non-Final OA | 44d overdue | Pending | Aug 31, 2023 |
| 18458230 | CONTAINER FOR STORING A BODILY FLUID | Dc Diagnostics Concept Ug (Haftungsbeschrankt) | SIEFKE, SAMUEL P | 1758 | §101 | Final Rejection | — | Pending | Aug 30, 2023 |
| 18339316 | ILLUMINATION DEVICE AND MICROSCOPY METHOD FOR GENERATING A COMPOSITE IMAGE OF A SAMPLE | Carl Zeiss Microscopy GmbH | ABDUR, RAHMAN | 2872 | §103 | Non-Final OA | 149d overdue | Pending | Jun 22, 2023 |
| 18257808 | IMMUNOGENIC COMPOSITIONS | The Scripps Research Institute | BOESEN, AGNIESZKA | 1672 | §102 | Final Rejection | 70d | Pending | Jun 15, 2023 |
| 18257814 | IMMUNOGENIC COMPOSITIONS | Fred Hutchinson Cancer Center | JUEDES, AMY E | 1644 | §101§102§112DP | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18252672 | PROGRAMMABLE NANO-REACTORS FOR STOCHASTIC SENSING (PNRSS) | Nanjing University | MUMMERT, STEPHANIE KANE | 1681 | §102 | Non-Final OA | — | Pending | May 11, 2023 |
| 18306580 | PERONOSPORA RESISTANCE IN SPINACIA OLERACEA | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | BOGGS, RUSSELL T | 1663 | §101§102§112DP | Non-Final OA | — | Pending | Apr 25, 2023 |
| 18163503 | RESISTANCE GENES AND PLANTS RESISTANT TO BEGOMOVIRUSES | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §102§112 | Non-Final OA | — | Pending | Feb 02, 2023 |
| 17904393 | AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2 | UCL Business PLC | WELLS, LAUREN QUINLAN | 1622 | §112DP | Non-Final OA | 87d overdue | Pending | Aug 17, 2022 |
| 17904388 | AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE | UCL Business Ltd | MCMILLIAN, KARA RENITA | 1623 | §102§112Other | Non-Final OA | — | Pending | Aug 17, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial87.7% of resolved applications prosecuted by Duane Morris LLP - Ny were allowed, across 13,370 applications in USPTO records.
3.37 office actions per allowed application on average.
29 pending office actions as of October 2026, for 12 clients, before 28 examiners in 18 art units.
